Business ❯ Healthcare ❯ Regulatory Affairs

FDA

Drug Approvals National Priority Voucher

Eli Lilly Unveils $3 Billion Netherlands Plant to Scale Production of Oral Weight‑Loss Pill

The timing positions Lilly to match supply to year‑end filings, potentially benefiting from an FDA priority voucher.

Regeneron Tops Q3 Forecasts on Dupixent Strength as Eylea HD Faces FDA Delay